Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases

Circulating microRNAs (miRNAs) are useful biomarkers of hemolysis. Since blood cells are the main origins of circulating miRNAs, we evaluated blood cell-related pre-analytical modification of the miRNA signatures during blood drawing and serum processing. The levels of miRNA before and after ex vivo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yukichi Takada, Tatsuki Shibuta, Mayu Hatano, Kenichi Sato, Mari Koga, Ayaka Ishibashi, Tetsuhiro Harada, Takashi Hisatomi, Hanae Shimura, Noriyasu Fukushima, Kamonlak Leecharoenkiat, Supat Chamnanchanunt, Saovaros Svasti, Suthat Fucharoen, Tsukuru Umemura
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/cb8720f49048446280d7d25817333391
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cb8720f49048446280d7d25817333391
record_format dspace
spelling oai:doaj.org-article:cb8720f49048446280d7d258173333912021-11-11T17:39:54ZPre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases10.3390/jcm102150452077-0383https://doaj.org/article/cb8720f49048446280d7d258173333912021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5045https://doaj.org/toc/2077-0383Circulating microRNAs (miRNAs) are useful biomarkers of hemolysis. Since blood cells are the main origins of circulating miRNAs, we evaluated blood cell-related pre-analytical modification of the miRNA signatures during blood drawing and serum processing. The levels of miRNA before and after ex vivo blood drawing were analyzed with the reverse transcriptase-based polymerase chain reaction method. Furthermore, the changes of miRNA signatures caused by different time-lag between blood drawing and serum preparation by 24 h were evaluated. Finally, we compared the miRNA levels between leftover samples and samples of hemolytic diseases. Blood drawing procedure induced increments of red blood cell (RBC)-related miRNAs (miR-451a, miR-486) about 2-fold. One hour standing of blood samples before serum separation induced almost the same increases in RBC-related miRNAs. To test the clinical usefulness of miR-451a as a biomarker of hemolytic diseases, we analyzed miRNAs of samples from 10 normal subjects, 30 leftover samples in the clinical laboratory, and 20 samples from patients with hemolytic diseases. Serum miR-451a significantly increased in patients with hemolytic anemia more than the levels of pre-analytical modification. In conclusion, the pre-analytical modification of serum miRNAs did not disturb the usefulness of RBC-derived miRNAs as biomarkers of hemolytic diseases.Yukichi TakadaTatsuki ShibutaMayu HatanoKenichi SatoMari KogaAyaka IshibashiTetsuhiro HaradaTakashi HisatomiHanae ShimuraNoriyasu FukushimaKamonlak LeecharoenkiatSupat ChamnanchanuntSaovaros SvastiSuthat FucharoenTsukuru UmemuraMDPI AGarticlemicroRNAmiR-451apre-analyticalblood drawingserum separationhemolytic diseaseMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5045, p 5045 (2021)
institution DOAJ
collection DOAJ
language EN
topic microRNA
miR-451a
pre-analytical
blood drawing
serum separation
hemolytic disease
Medicine
R
spellingShingle microRNA
miR-451a
pre-analytical
blood drawing
serum separation
hemolytic disease
Medicine
R
Yukichi Takada
Tatsuki Shibuta
Mayu Hatano
Kenichi Sato
Mari Koga
Ayaka Ishibashi
Tetsuhiro Harada
Takashi Hisatomi
Hanae Shimura
Noriyasu Fukushima
Kamonlak Leecharoenkiat
Supat Chamnanchanunt
Saovaros Svasti
Suthat Fucharoen
Tsukuru Umemura
Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
description Circulating microRNAs (miRNAs) are useful biomarkers of hemolysis. Since blood cells are the main origins of circulating miRNAs, we evaluated blood cell-related pre-analytical modification of the miRNA signatures during blood drawing and serum processing. The levels of miRNA before and after ex vivo blood drawing were analyzed with the reverse transcriptase-based polymerase chain reaction method. Furthermore, the changes of miRNA signatures caused by different time-lag between blood drawing and serum preparation by 24 h were evaluated. Finally, we compared the miRNA levels between leftover samples and samples of hemolytic diseases. Blood drawing procedure induced increments of red blood cell (RBC)-related miRNAs (miR-451a, miR-486) about 2-fold. One hour standing of blood samples before serum separation induced almost the same increases in RBC-related miRNAs. To test the clinical usefulness of miR-451a as a biomarker of hemolytic diseases, we analyzed miRNAs of samples from 10 normal subjects, 30 leftover samples in the clinical laboratory, and 20 samples from patients with hemolytic diseases. Serum miR-451a significantly increased in patients with hemolytic anemia more than the levels of pre-analytical modification. In conclusion, the pre-analytical modification of serum miRNAs did not disturb the usefulness of RBC-derived miRNAs as biomarkers of hemolytic diseases.
format article
author Yukichi Takada
Tatsuki Shibuta
Mayu Hatano
Kenichi Sato
Mari Koga
Ayaka Ishibashi
Tetsuhiro Harada
Takashi Hisatomi
Hanae Shimura
Noriyasu Fukushima
Kamonlak Leecharoenkiat
Supat Chamnanchanunt
Saovaros Svasti
Suthat Fucharoen
Tsukuru Umemura
author_facet Yukichi Takada
Tatsuki Shibuta
Mayu Hatano
Kenichi Sato
Mari Koga
Ayaka Ishibashi
Tetsuhiro Harada
Takashi Hisatomi
Hanae Shimura
Noriyasu Fukushima
Kamonlak Leecharoenkiat
Supat Chamnanchanunt
Saovaros Svasti
Suthat Fucharoen
Tsukuru Umemura
author_sort Yukichi Takada
title Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
title_short Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
title_full Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
title_fullStr Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
title_full_unstemmed Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
title_sort pre-analytical modification of serum mirnas: diagnostic reliability of serum mirnas in hemolytic diseases
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/cb8720f49048446280d7d25817333391
work_keys_str_mv AT yukichitakada preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT tatsukishibuta preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT mayuhatano preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT kenichisato preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT marikoga preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT ayakaishibashi preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT tetsuhiroharada preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT takashihisatomi preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT hanaeshimura preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT noriyasufukushima preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT kamonlakleecharoenkiat preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT supatchamnanchanunt preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT saovarossvasti preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT suthatfucharoen preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
AT tsukuruumemura preanalyticalmodificationofserummirnasdiagnosticreliabilityofserummirnasinhemolyticdiseases
_version_ 1718432025950552064